LIBERATE AI LIMITED

What LIBERATE AI LIMITED does

LIBERATE AI Limited is a UK-based Precision Health AI company founded in 2019 that builds software to automate the management of patients with Long-Term Conditions (LTCs) for NHS Primary Care. The company's flagship product, Nightingale, is a Patient Pathway Automation Solution that automates call-and-recall workflows and care pathways for conditions such as Asthma, Diabetes, Chronic Kidney Disease, Chronic Heart Disease, COPD, and Hypertension. Nightingale was co-developed with over 500 NHS Primary Care clinicians and is certified for deployment against TTP SystmOne and EMIS, the EHR systems used by the majority of UK Primary Care.

The technical stack is built on three proprietary platforms: the Fleming AI Platform, which manages the full lifecycle of training and deploying healthcare ML/AI models; the Maxwell Data Vault, a federated health data platform that integrates multiple EHR systems; and the Franklin suite of applications, including Franklin Deep Patient Insight (predicting hospitalisation risk with up to 90% accuracy 3-6 months in advance) and Franklin Demand Management. Liberate AI also holds patent-pending Knowledge Protection Technologies that safeguard trained AI models and clinical know-how.

The company operates a B2B enterprise go-to-market, delivering solutions through both public-cloud SaaS (AWS, Azure) and on-premises private cloud deployment models, supported by professional services for change management. Pricing is quote-based and not publicly disclosed. Customers are UK NHS Primary Care practices and clinical commissioning groups, with secondary care addressed upstream through Franklin DPI. The company is privately held with no disclosed external funding rounds; ownership rests with founder-CEO Belinda Roelofs, founder-CTO Nicholas Kassem, and founder-advisor Sir Hossein Yassaie.

Name

LIBERATE AI LIMITED

Legal name

LIBERATE AI Limited

Website

https://liberate-ai.com

Company type

Private

Founded year

2019

Operating status

Operating

Short description

UK-based Precision Health AI company founded in 2019 that builds the Nightingale patient pathway automation platform for NHS Primary Care, automating Long-Term Condition management on a proprietary Fleming AI Platform and Maxwell Data Vault, and delivering Franklin predictive applications for hospitalisation risk and clinical demand.

Ownership category

akta.pro rank

Product category

Healthcare AI Software

NAICS

Software Publishers (5132), Computer Systems Design and Related Services (54151), Custom Computer Programming Services (541511)

SIC

Services-Prepackaged Software (7372), Services-Computer Integrated Systems Design (7373), Services-Computer Programming, Data Processing, Etc. (7370)

akta.pro primary industry

End-to-End Enterprise AI Platforms (MLOps & Model Lifecycle Management) (HDAEANAA)

akta.pro secondary industries

Responsible AI, Security & Privacy Platforms (Safety, Guardrails, PII) (HDAEANAG), AI Application Enablement Platforms (Copilot/Agent Frameworks, SDKs) (HDAEANAJ), AI Integration & Orchestration Platforms (Connectors, Workflow, iPaaS for AI) (HDAEANAI), AI/ML Engineering & Model Development Services (BPAEAHAF), AI Observability, Monitoring & Evaluation Platforms (Drift, Quality, Safety) (HDAEANAF)

Keywords

• Healthcare AI solutions
• Patient pathway automation
• Predictive health analytics
• Electronic health records
• Precision medicine

Headquarters

HQ city

London

HQ country

United Kingdom

HQ region

Europe

Offices1 record

Markets served

GTM type

B2B

Offering type

Software

Cost components

Personnel, Technology or R&D, Infrastructure, Marketing or Sales, Operations

Revenue model

1. Public Cloud Hosted SaaS: State of the art Health Applications and FLEMING AI Platform hosted on Public Cloud services such as AWS and Azure as Software as a Service. Liberate AI provides full operation of the platform and help desk support.
2. On-Prem Private Cloud SaaS: AI Platform and Applications hosted at customer Data Centre and on customer servers with full first line, second line and third line Support and Operations services. Provides maximum peace of mind for organisations wanting to assure data privacy.
3. Delivery Management Services: Expert team enables smooth and rapid deployment of applications with structured and rigorous change management program to ensure applications are integrated within current processes without disruption.

Go-to-market motion2 records

Distribution channels2 records

Marketing channels1 record

Core offering

LIBERATE AI Limited develops and sells Precision Health AI software for NHS Primary Care, headlined by the Nightingale Patient Pathway Automation Solution that automates Long-Term Condition (LTC) management for Asthma, Diabetes, CKD, CHD, COPD, and Hypertension. The offering is built on three foundational platforms: the Fleming AI Platform (development/deployment of trained ML/AI models), the Maxwell Data Vault (federated integration of Electronic Health Record Systems), and the Franklin applications (Deep Patient Insight and Demand Management). Deployment is via public cloud SaaS or on-premise private cloud with full support.

Product overview

LIBERATE AI LIMITED provides a comprehensive Precision Health AI Solutions ecosystem built on three foundational platforms. The core offering is Nightingale, an award-winning Patient Pathway Automation Solution that automates Long-Term Condition patient management. Fleming AI Platform serves as the underlying technology for all AI development and deployment. Franklin applications provide Deep Patient Insight (predicting hospitalisation risk with 90% accuracy) and Demand Management capabilities. Maxwell Data Vault provides the federated health data infrastructure that unifies data from multiple EHR systems. These products work together to deliver proactive preventative care, with Nightingale deployed at scale in NHS Primary Care.

Differentiator

Problem solved

Functional benefit

Brands

• Nightingale: Award-winning Patient Pathway Automation Solution for NHS Primary Care, automating management of patients with Long-Term Conditions (LTCs) including Asthma, Diabetes, CKD, CHD, COPD, and Hypertension
• Franklin
• Maxwell
• Fleming

Products and services

• Nightingale Patient Pathway Automation Solution Award-winning Patient Pathway Automation Solution developed with over 500 NHS Primary Care clinicians that automates complex Long-Term Condition (LTC) patient pathways and call/recall processes for NHS Primary Care GP practices and clinical commissioning groups.
• FRANKLIN Deep Patient Insight (DPI) AI-powered application that predicts patients at risk of hospitalisation in the next 3-6 months with up to 90% accuracy, enabling prioritisation of at-risk patients upstream at primary care to reduce pressure on secondary care.
• FRANKLIN Demand Management Application

Quantifiable outcome

• 53% reduction in clinical appointments required
• +7 more outcomes

Named customers2 records

Segments2 records

Ideal customer profiles2 records

Technology focussed Yes

API detail

Has API

No

API docs

API detail

Core technology

AI maturity

App detail

Integration3 records

AI capability3 records

Feature8 records

Partnerships

Two partnerships are on record, tiered core.

• NHS Primary Care Group (500+ clinicians)coreStrategic or Co-development PartnerNightingale Patient Pathway Automation solution was jointly developed with one of the largest NHS Primary Care Groups and over 500 NHS Primary Care clinicians. This collaboration reflects and captures the best experience and needs of NHS Primary Care, designed to revolutionise patient access and care pathways. The solution reflects the longstanding challenge of the Call & Recall process for patients with Long-Term Conditions.
• NHS (Strategic Partner)coreStrategic or Co-development PartnerLiberate AI operates as a strategic AI partner to the NHS in the UK, using AI to improve patient outcomes by increasing operational efficiencies and patient access to the right care at the right time through precision care solutions.

Scale indicators7 records

Recent moves6 records

Expansion highlights5 records

Direct peers

• Huma: UK-headquartered digital health platform combining patient-facing apps, remote monitoring and AI-driven predictive models for NHS and global health systems. Most directly comparable in geography, NHS orientation and AI-clinical risk prediction overlap.
• Ada Health: AI-based clinical decision support and symptom-assessment platform used by health systems, insurers and consumers. Comparable as enterprise AI for clinical assessment and triage with measurable outcomes.
• K Health: AI-first primary care platform combining predictive models with virtual consultations for chronic and acute conditions. Comparable operating model in AI-enabled chronic disease management at primary-care layer.
• ClosedLoop.ai: Healthcare-specific predictive analytics and AI platform for risk stratification, quality measurement and population health. Comparable as a healthcare ML model lifecycle and prediction platform.
• Sensyne Health (Arcturis): UK health AI company focused on applying machine learning to NHS clinical data to improve patient outcomes and operational efficiency. Comparable as an NHS-data-driven AI clinical decision support peer.
• Syntegra: Federated synthetic data and analytics platform for healthcare that links across multiple EHR and clinical systems without moving raw data. Comparable as a federated health data infrastructure layer for AI development.
• ieso Digital Health: UK-based AI-driven therapy and clinical decision support provider integrated with NHS pathways. Comparable as NHS-deployed AI clinical decision support operating against UK GP and mental health workflows.

Broad incumbents

• Doctolib: Large European digital health platform spanning appointment booking, teleconsultation and patient pathway management. Comparable in patient pathway automation and chronic care appointment workflows at national scale.
• Kry (Livi): European digital primary care provider offering AI-assisted triage and video GP consultations across multiple NHS contracts. Comparable in AI-supported primary care access and chronic care management.

Emerging players

• accuRx: UK NHS-primary-care platform for messaging, triage and patient communication, deeply integrated with EMIS and SystmOne. Comparable in NHS IM1-style integration approach and primary-care clinical workflow automation.

Market position

Strengths5 records

Weaknesses5 records

Competitive moat5 records

Key risks5 records

Key highlights7 records

Customer concentration

Compliance3 records

Revenue estimate

Valuation estimate

Number of profiles

Profiles5 records

Funding overview

Funding rounds

Investors

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about LIBERATE AI LIMITED